Terri S. Armstrong, Ph.D., N.P. - Publications

Affiliations: 
1996-2000 Neurosurgery Winship Cancer Institue, Emory University 
 2000-2016 Neuro-Oncology M.D. Anderson Cancer Center, Houston, TX, United States 
 2003-2016 School of Nursing University of Texas, Health Science Center at Houston 
 2016- Neuro-Oncology Branch CCR, NCI, NIH 
Area:
symptom assessment, management, myelotoxicity
Website:
https://nursing.uth.edu/directory/profile/index.htm?profileinode=f1040d2a-3e1a-472f-9171-479f7af0f4dc

185 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Jammula VR, Leeper H, Gilbert MR, Cooper D, Armstrong TS. Effects of Cognitive Reserve on Cognition in Individuals With Central Nervous System Disease. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. PMID 34508028 DOI: 10.1097/WNN.0000000000000282  1
2021 Pang Y, Yu G, Butler M, Sindiri S, Song YK, Wei JS, Wen X, Chou HC, Quezado M, Pack S, Xi L, Abdullaev Z, Kim O, Ranjan A, Merchant M, ... ... Armstrong TS, et al. Report of Canonical - Fusion in Glioblastoma. Jco Precision Oncology. 5. PMID 34485806 DOI: 10.1200/PO.20.00519  1
2021 Sievers P, Henneken SC, Blume C, Sill M, Schrimpf D, Stichel D, Okonechnikov K, Reuss DE, Benzel J, Maaß KK, Kool M, Sturm D, Zheng T, Ghasemi DR, Kohlhof-Meinecke P, ... ... Armstrong TS, et al. Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors. Acta Neuropathologica. PMID 34355256 DOI: 10.1007/s00401-021-02356-6  1
2021 Al Feghali KA, Randall JW, Liu DD, Wefel JS, Brown PD, Grosshans DR, McAvoy SA, Farhat MA, Li J, McGovern SL, McAleer MF, Ghia AJ, Paulino AC, Sulman EP, Penas-Prado M, ... ... Armstrong TS, et al. Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment. Neuro-Oncology Advances. 3: vdab073. PMID 34337411 DOI: 10.1093/noajnl/vdab073  1
2021 Chukwueke UN, Vera E, Acquaye A, Hervey-Jumper SL, Odia Y, Klesse LJ, Dunbar E, Sharma A, Fonkem E, Thomas AA, Werbowetski-Ogilvie TE, Camelo-Piragua S, Gatson NTN, de la Fuente MI, Armstrong TS, et al. SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology. Neuro-Oncology. PMID 34302487 DOI: 10.1093/neuonc/noab172  1
2021 Rogers JL, Vera E, Acquaye A, Briceno N, Jammula V, King AL, Leeper H, Quezado MM, Gonzalez Alarcon J, Boris L, Burton E, Celiku O, Choi A, Christ A, Crandon S, ... ... Armstrong TS, et al. Living with a central nervous system (CNS) tumor: findings on long-term survivorship from the NIH Natural History Study. Neuro-Oncology Practice. 8: 460-474. PMID 34277024 DOI: 10.1093/nop/npab022  1
2021 Dirven L, Vos ME, Walbert T, Armstrong TS, Arons D, van den Bent MJ, Blakeley J, Brown PD, Bulbeck H, Chang SM, Coens C, Gilbert MR, Grant R, Jalali R, Leach D, et al. Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiative. Neuro-Oncology Practice. 8: 417-425. PMID 34277020 DOI: 10.1093/nop/npab013  1
2021 De La Cruz Minyety J, Shuboni-Mulligan DD, Briceno N, Young D, Gilbert MR, Celiku O, Armstrong TS. Association of Circadian Clock Gene Expression with Glioma Tumor Microenvironment and Patient Survival. Cancers. 13. PMID 34199348 DOI: 10.3390/cancers13112756  1
2021 De La Cruz Minyety J, Shuboni-Mulligan DD, Briceno N, Young D, Gilbert MR, Celiku O, Armstrong TS. Association of Circadian Clock Gene Expression with Glioma Tumor Microenvironment and Patient Survival. Cancers. 13. PMID 34199348 DOI: 10.3390/cancers13112756  1
2021 Withrow DR, Devesa SS, Deapen D, Petkov V, Van Dyke AL, Adamo M, Armstrong TS, Gilbert MR, Linet MS. Nonmalignant meningioma and vestibular schwannoma incidence trends in the United States, 2004-2017. Cancer. PMID 34160068 DOI: 10.1002/cncr.33553  1
2021 Leeper HE, Diane Cooper I, Armstrong TS. Palliative Care Intervention Trials for Adults Living with Progressive Central Nervous System Diseases and Their Caregivers: A Systematic Review. Journal of Pain and Symptom Management. PMID 34147576 DOI: 10.1016/j.jpainsymman.2021.06.010  1
2021 Leeper HE, Diane Cooper I, Armstrong TS. Palliative Care Intervention Trials for Adults Living with Progressive Central Nervous System Diseases and Their Caregivers: A Systematic Review. Journal of Pain and Symptom Management. PMID 34147576 DOI: 10.1016/j.jpainsymman.2021.06.010  1
2021 Mrugala MM, Ostrom QT, Pressley SM, Taylor JW, Thomas AA, Wefel JS, Coven SL, Acquaye AA, Haynes C, Agnihotri S, Lim M, Peters KB, Sulman EP, Salcido JT, Butowski NA, ... ... Armstrong TS, et al. The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment. Neuro-Oncology Advances. 3: vdab035. PMID 34007966 DOI: 10.1093/noajnl/vdab035  1
2021 Shuboni-Mulligan DD, Young DL, De La Cruz Minyety J, Vera E, Munasinghe J, Gall AJ, Gilbert MR, Armstrong TS, Smart DK. Impact of age on the circadian visual system and the sleep-wake cycle in mus musculus. Npj Aging and Mechanisms of Disease. 7: 10. PMID 33947857 DOI: 10.1038/s41514-021-00063-w  1
2021 Wu J, Yuan Y, Long Priel DA, Fink D, Peer CJ, Sissung TM, Su YT, Pang Y, Yu G, Butler MK, Mendoza TR, Vera E, Ahmad S, Bryla C, Lindsley M, ... ... Armstrong TS, et al. Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33785481 DOI: 10.1158/1078-0432.CCR-20-4730  1
2021 Brown PD, Chung C, Liu DD, McAvoy S, Grosshans D, Al Feghali K, Mahajan A, Li J, McGovern SL, McAleer MF, Ghia AJ, Sulman EP, Penas-Prado M, de Groot JF, Heimberger AB, ... ... Armstrong TS, et al. A Prospective Phase II Randomized Trial of Proton Radiotherapy vs. Intensity Modulated Radiotherapy for Patients with Newly Diagnosed Glioblastoma. Neuro-Oncology. PMID 33647972 DOI: 10.1093/neuonc/noab040  1
2021 Baroni L, Sundaresan L, Heled A, Coltin H, Pajtler KW, Lin T, Merchant TE, McLendon R, Faria C, Buntine M, White CL, Pfister SM, Gilbert MR, Armstrong TS, Bouffet E, et al. Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q. Neuro-Oncology. PMID 33580238 DOI: 10.1093/neuonc/noab034  1
2021 Wefel JS, Armstrong TS, Pugh SL, Gilbert MR, Wendland MM, Brachman DG, Roof KS, Brown PD, Crocker IR, Robins HI, Hunter G, Won M, Mehta MP. Neurocognitive, Symptom, and Health- Related Quality of Life Outcomes of a Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma (NRG/RTOG 0825). Neuro-Oncology. PMID 33515019 DOI: 10.1093/neuonc/noab011  1
2020 Penas-Prado M, Wu J, Cahill DP, Brat DJ, Costello JF, Kluetz PG, Cairncross JG, van den Bent M, Verhaak RGW, Aboud O, Burger P, Chang SM, Cordova C, Huang RY, Rowe LS, ... ... Armstrong TS, et al. Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Oligodendroglioma Workshop. Neuro-Oncology Advances. 2: vdz048. PMID 33289010 DOI: 10.1093/noajnl/vdz048  1
2020 Penas-Prado M, Armstrong TS, Gilbert MR. Proposed Additions to the NCCN Guidelines for Adult Medulloblastoma. Journal of the National Comprehensive Cancer Network : Jnccn. 18: 1579-1584. PMID 33152706 DOI: 10.6004/jnccn.2020.7650  1
2020 Gilbert MR, Yuan Y, Wu J, Mendoza T, Vera E, Omuro A, Lieberman F, Robins HI, Gerstner ER, Wu J, Wen PY, Mikkelsen T, Aldape K, Armstrong TS. A Phase II Study of Dose-Dense Temozolomide and Lapatinib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma. Neuro-Oncology. PMID 33085768 DOI: 10.1093/neuonc/noaa240  1
2020 Leggiero NM, Armstrong TS, Gilbert MR, King AL. Use of virtual reality for symptom management in solid-tumor patients with implications for primary brain tumor research: a systematic review. Neuro-Oncology Practice. 7: 477-489. PMID 33014388 DOI: 10.1093/Nop/Npaa012  1
2020 Penas-Prado M, Theeler BJ, Cordeiro B, Dunkel IJ, Hau P, Mahajan A, Robinson GW, Willmarth N, Aboud O, Aldape K, Butman JA, Gajjar A, Kelly W, Rao G, Raygada M, ... ... Armstrong TS, et al. Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Adult Medulloblastoma Workshop. Neuro-Oncology Advances. 2: vdaa097. PMID 33005896 DOI: 10.1093/noajnl/vdaa097  1
2020 Lynes J, Acquaye AA, Sur H, Nwankwo A, Sanchez V, Vera E, Wu T, Theeler B, Armstrong TS, Gilbert MR, Nduom EK. Variations in attitudes towards stereotactic biopsy of adult diffuse midline glioma patients: a survey of members of the AANS/CNS Tumor Section. Journal of Neuro-Oncology. PMID 32705457 DOI: 10.1007/S11060-020-03585-7  1
2020 Raffeld M, Abdullaev Z, Pack SD, Xi L, Nagaraj S, Briceno N, Vera E, Pittaluga S, Lopes Abath Neto O, Quezado M, Aldape K, Armstrong TS, Gilbert MR. High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma. Acta Neuropathologica Communications. 8: 101. PMID 32641156 DOI: 10.1186/S40478-020-00973-Y  1
2020 Hui D, De La Rosa A, Wilson A, Nguyen T, Wu J, Delgado-Guay M, Azhar A, Arthur J, Epner D, Haider A, De La Cruz M, Heung Y, Tanco K, Dalal S, Reddy A, ... ... Armstrong TS, et al. Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial. The Lancet. Oncology. PMID 32479786 DOI: 10.1016/S1470-2045(20)30307-7  1
2020 Armstrong TS, Chang SM, Jenkinson D, Kluetz P, Taphoorn MJB. Glioma patient-reported outcome assessment in clinical care - Authors' reply. The Lancet. Oncology. 21: e231. PMID 32359496 DOI: 10.1016/S1470-2045(20)30241-2  1
2020 Penas-Prado M, Armstrong TS, Gilbert MR. Letter to the Editor Re: Mohile et al. Neuro-Oncology. PMID 32343803 DOI: 10.1093/Neuonc/Noaa109  1
2020 Tanaka S, Sato I, Takahashi M, Armstrong TS, Cleeland CS, Mendoza TR, Mukasa A, Takayanagi S, Narita Y, Kamibeppu K, Saito N. Validation study of the Japanese version of MD Anderson Symptom Inventory for Brain Tumor module. Japanese Journal of Clinical Oncology. PMID 32280995 DOI: 10.1093/Jjco/Hyaa036  1
2020 Zimmer AS, Steinberg SM, Smart DD, Gilbert MR, Armstrong TS, Burton E, Houston N, Biassou N, Gril B, Brastianos PK, Carter S, Lyden D, Lipkowitz S, Steeg PS. Temozolomide in secondary prevention of HER2-positive breast cancer brain metastases. Future Oncology (London, England). PMID 32270710 DOI: 10.2217/Fon-2020-0094  1
2020 Rogers JL, Acquaye A, Vera E, Bates A, Wen PY, Armstrong TS. Provider-reported challenges and barriers to referring patients to neuro-oncology clinical trials: a report from the Society for Neuro-Oncology member survey. Neuro-Oncology Practice. 7: 38-51. PMID 32257283 DOI: 10.1093/Nop/Npz038  1
2020 Puduvalli VK, Wu J, Yuan Y, Armstrong TS, Vera E, Wu J, Xu J, Giglio P, Colman H, Walbert T, Raizer J, Groves MD, Tran D, Iwamoto F, Avgeropoulos N, et al. A Bayesian Adaptive Randomized Phase II Multicenter Trial of Bevacizumab with or without Vorinostat in Adults with Recurrent Glioblastoma. Neuro-Oncology. PMID 32166308 DOI: 10.1093/Neuonc/Noaa062  1
2020 Rowe L, Vera E, Acquaye A, Crandon S, Shah V, Bryla C, Wu J, Wall K, Siegel C, Reyes J, Penas-Prado M, Leggiero N, Cordova C, Burton E, Antony R, ... ... Armstrong T, et al. The prevalence of altered body image in patients with primary brain tumors: an understudied population. Journal of Neuro-Oncology. PMID 32096067 DOI: 10.1007/S11060-020-03433-8  1
2020 Brown PD, Gondi V, Pugh S, Tome WA, Wefel JS, Armstrong TS, Bovi JA, Robinson C, Konski A, Khuntia D, Grosshans D, Benzinger TLS, Bruner D, Gilbert MR, Roberge D, et al. Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902767. PMID 32058845 DOI: 10.1200/Jco.19.02767  1
2020 Armstrong TS, Dirven L, Arons D, Bates A, Chang SM, Coens C, Espinasse C, Gilbert MR, Jenkinson D, Kluetz P, Mendoza T, Rubinstein L, Sul J, Weller M, Wen PY, et al. Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report. The Lancet. Oncology. 21: e97-e103. PMID 32007210 DOI: 10.1016/S1470-2045(19)30796-X  1
2020 Theeler BJ, Jung J, Burton E, Gonzalez J, Leeper H, Wu J, Nduom E, Zaghloul K, Ray-Chaudhury A, Quezado M, Raffeld M, Allen JE, Prabhu VV, Stogniew M, Oster W, ... ... Armstrong T, et al. A first-in-human phase I single-agent dose-escalation, food effect and dose expansion study of oral ONC206 in recurrent and rare primary central nervous system neoplasms. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.Tps2576  1
2019 Yust-Katz S, O'Brien B, Vera E, Acquaye A, Weller M, Armstrong T. Burnout and Career Satisfaction in Neuro-Oncology: A Survey of the Society for Neuro-Oncology and the European Association of Neuro-Oncology Membership. Neuro-Oncology. PMID 31832657 DOI: 10.1093/Neuonc/Noz229  1
2019 Robins HI, Eickhoff J, Gilbert MR, Armstrong TS, Shi W, De Groot JF, Schultz CJ, Hunter GK, Valeinis E, Roach M, Youssef EF, Souhami L, Howard SP, Lieberman FS, Herman JG, et al. The association between BMI and BSA-temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525. Neuro-Oncology Practice. 6: 473-478. PMID 31832217 DOI: 10.1093/Nop/Npz006  1
2019 Armstrong TS. "The value of experience is not in seeing much, but in seeing wisely" . Neuro-Oncology Practice. 6: 413-414. PMID 31832210 DOI: 10.1093/Nop/Npz061  0.01
2019 Shuboni-Mulligan DD, Breton G, Smart D, Gilbert M, Armstrong TS. Radiation chronotherapy-clinical impact of treatment time-of-day: a systematic review. Journal of Neuro-Oncology. PMID 31729636 DOI: 10.1007/S11060-019-03332-7  1
2019 Penas-Prado M, Armstrong TS, Gilbert MR. Progress in rare central nervous system tumors. Current Opinion in Neurology. PMID 31577601 DOI: 10.1097/Wco.0000000000000755  1
2019 Acquaye AA, Payén SS, Vera E, Williams LA, Gilbert MR, Weathers SP, Armstrong TS. Identifying symptom recurrences in primary brain tumor patients using the MDASI-BT and qualitative interviews. Journal of Patient-Reported Outcomes. 3: 58. PMID 31444579 DOI: 10.1186/S41687-019-0143-0  1
2019 Milbury K, Li J, Weathers SP, Mallaiah S, Armstrong T, Li Y, Bruera E, Cohen L. Pilot randomized, controlled trial of a dyadic yoga program for glioma patients undergoing radiotherapy and their family caregivers. Neuro-Oncology Practice. 6: 311-320. PMID 31386042 DOI: 10.1093/Nop/Npy052  1
2019 Wen PY, Reardon DA, Armstrong TS, Phuphanich S, Aiken RD, Landolfi JC, Curry WT, Zhu JJ, Glantz M, Peereboom DM, Markert J, LaRocca R, O'Rourke DM, Fink K, Kim L, et al. A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31320597 DOI: 10.1158/1078-0432.Ccr-19-0261  1
2019 Truitt G, Gittleman H, Leece R, Ostrom QT, Kruchko C, Armstrong TS, Gilbert MR, Barnholtz-Sloan JS. Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT. Journal of Neuro-Oncology. PMID 31209773 DOI: 10.1007/S11060-019-03215-X  1
2019 Lee EQ, Chukwueke UN, Hervey-Jumper SL, de Groot JF, Leone JP, Armstrong TS, Chang SM, Arons D, Oliver K, Verble K, Musella A, Willmarth N, Alexander BM, Bates A, Doherty L, et al. Barriers to Accrual and Enrollment in Brain Tumor Trials. Neuro-Oncology. PMID 31175826 DOI: 10.1093/Neuonc/Noz104  1
2019 Waddle MR, Oudenhoven MD, Farin CV, Deal AM, Hoffman R, Yang H, Peterson J, Armstrong TS, Ewend MG, Wu J. Impacts of Surgery on Symptom Burden and Quality of Life in Pituitary Tumor Patients in the Subacute Post-operative Period. Frontiers in Oncology. 9: 299. PMID 31065545 DOI: 10.3389/Fonc.2019.00299  1
2019 Schiff D, van den Bent M, Vogelbaum MA, Wick W, Miller CR, Taphoorn M, Pope W, Brown PD, Platten M, Jalali R, Armstrong T, Wen PY. Recent Developments and Future Directions in Adult Lower-Grade Gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) Consensus. Neuro-Oncology. PMID 30753579 DOI: 10.1093/Neuonc/Noz033  1
2019 Taylor JW, Armstrong T, Kim AH, Venere M, Acquaye A, Schrag D, Wen PY. The lomustine crisis: awareness and impact of the 1500% price hike. Neuro-Oncology. 21: 1-3. PMID 30590838 DOI: 10.1093/neuonc/noy189  1
2019 Taylor JW, Armstrong T, Kim AH, Venere M, Acquaye A, Schrag D, Wen PY. The lomustine crisis: awareness and impact of the 1500% price hike. Neuro-Oncology. 21: 1-3. PMID 30590836 DOI: 10.1093/Neuonc/Noy189  1
2018 Leeper HE, Acquaye AA, Bell S, Clarke JL, Forst D, Laack NN, Link MJ, Taylor JW, Armstrong TS. Survivorship care planning in neuro-oncology. Neuro-Oncology Practice. 5: 3-9. PMID 31386011 DOI: 10.1093/Nop/Npx034  1
2018 Manier KK, Rowe LS, Welsh J, Armstrong TS. The impact and incidence of altered body image in patients with head and neck tumors: a systematic review. Neuro-Oncology Practice. 5: 204-213. PMID 31386002 DOI: 10.1093/nop/npy018  0.01
2018 Armstrong TS, Vera E, Zhou R, Acquaye AA, Sullaway CM, Berger AM, Breton G, Mahajan A, Wefel JS, Gilbert MR, Bondy M, Scheurer ME. Association of genetic variants with fatigue in patients with malignant glioma. Neuro-Oncology Practice. 5: 122-128. PMID 31386001 DOI: 10.1093/Nop/Npx020  1
2018 Vera E, Acquaye AA, Mendoza TR, Gilbert MR, Armstrong TS. Relationship between symptom burden and health status: analysis of the MDASI-BT and EQ-5D. Neuro-Oncology Practice. 5: 56-63. PMID 31385972 DOI: 10.1093/Nop/Npx010  1
2018 Siegel C, Armstrong TS. Nursing Guide to Management of Major Symptoms in Patients with Malignant Glioma. Seminars in Oncology Nursing. PMID 30424920 DOI: 10.1016/j.soncn.2018.10.014  0.01
2018 Armstrong TS. Survivorship in Neuro-Oncology. Neuro-Oncology. 20: vii4-vii5. PMID 30412259 DOI: 10.1093/Neuonc/Noy173  0.01
2018 Cavalli FMG, Hübner JM, Sharma T, Luu B, Sill M, Zapotocky M, Mack SC, Witt H, Lin T, Shih DJH, Ho B, Santi M, Emery L, Hukin J, Dunham C, ... ... Armstrong TS, et al. Heterogeneity within the PF-EPN-B ependymoma subgroup. Acta Neuropathologica. PMID 30019219 DOI: 10.1007/S00401-018-1888-X  1
2018 Arvold ND, Armstrong TS, Warren KE, Chang SM, DeAngelis LM, Blakeley J, Chamberlain MC, Dunbar E, Loong HH, Macdonald DR, Reardon DA, Vogelbaum MA, Yuan Y, Weller M, van den Bent M, et al. Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group. Neuro-Oncology. PMID 29788429 DOI: 10.1093/Neuonc/Noy056  1
2018 Walker J, O'Brien B, Vera E, Armstrong T. Describing Symptom Burden and Functional Status at the Diagnosis of Leptomeningeal Metastasis. Oncology Nursing Forum. 45: 372-379. PMID 29683126 DOI: 10.1188/18.Onf.372-379  1
2018 Hall WA, Pugh SL, Wefel JS, Armstrong TS, Gilbert MR, Brachman DG, Werner-Wasik M, Wendland MM, Brown PD, Chao ST, Roof KS, Robins HI, Mehta MP, Curran WJ, Movsas B. Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes. Neurosurgery. PMID 29618054 DOI: 10.1093/Neuros/Nyy003  1
2018 Jordan JT, Sanders AE, Armstrong T, Asher T, Bennett A, Dunbar E, Mohile N, Nghiemphu PL, Smith TR, Ney DE. Quality improvement in neurology: Neuro-Oncology Quality Measurement Set. Neuro-Oncology. PMID 29509930 DOI: 10.1093/Neuonc/Nox245  1
2018 Dirven L, Armstrong TS, Blakeley JO, Brown PD, Grant R, Jalali R, Leeper H, Mendoza T, Nayak L, Reijneveld JC, Rhun EL, Walbert T, Weller M, Wen PY, Taphoorn MJB. Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiative. The Lancet. Oncology. 19: e173-e180. PMID 29508764 DOI: 10.1016/S1470-2045(18)30004-4  1
2018 Jordan JT, Sanders AE, Armstrong T, Asher T, Bennett A, Dunbar E, Mohile N, Nghiemphu PL, Smith TR, Ney DE. Quality improvement in neurology: Neuro-oncology quality measurement set. Neurology. PMID 29500290 DOI: 10.1212/WNL.0000000000005251  1
2017 Yust Katz S, Cachia D, Kamiya-Matsuoka C, Olar A, Theeler B, Penas Prado M, Gilbert MR, Armstrong T. Corrigendum to 'Ependymomas arising outside of the central nervous system: A case series and literature review' [J Clin Neurosci 47 (2018) 202-207]. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 29295763 DOI: 10.1016/J.Jocn.2017.12.011  1
2017 Aggarwal SS, Ott SD, Padhye NS, Meininger JC, Armstrong TS. Clinical and demographic predictors of concussion resolution in adolescents: A retrospective study. Applied Neuropsychology. Child. 1-11. PMID 29058480 DOI: 10.1080/21622965.2017.1381099  1
2017 Yust Katz S, Cachia D, Kamiya Matsuok C, Olar A, Theeler B, Penas Prado M, Gilbert MR, Armstrong T. Ependymomas arising outside of the central nervous system: A case series and literature review. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 29054328 DOI: 10.1016/J.Jocn.2017.10.026  1
2017 Milbury K, Mallaiah S, Mahajan A, Armstrong T, Weathers SP, Moss KE, Goktepe N, Spelman A, Cohen L. Yoga Program for High-Grade Glioma Patients Undergoing Radiotherapy and Their Family Caregivers. Integrative Cancer Therapies. 1534735417689882. PMID 28150503 DOI: 10.1177/1534735417689882  1
2016 Mallaiah S, Mahajan A, Armstrong TS, Weathers SS, Moss KE, Goktepe N, Spelman A, Cohen L. Yoga program for patients with brain tumors undergoing radiotherapy (XRT) and their family caregivers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 200. PMID 28156607 DOI: 10.1200/Jco.2016.34.26_Suppl.200  1
2016 Sulman EP, Ismaila N, Armstrong TS, Tsien C, Batchelor TT, Cloughesy T, Galanis E, Gilbert M, Gondi V, Lovely M, Mehta M, Mumber MP, Sloan A, Chang SM. Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016707562. PMID 27893327 DOI: 10.1200/Jco.2016.70.7562  1
2016 Acquaye AA, Vera E, Gilbert MR, Armstrong TS. Clinical presentation and outcomes for adult ependymoma patients. Cancer. PMID 27679985 DOI: 10.1002/Cncr.30355  1
2016 Avila EK, Chamberlain M, Schiff D, Reijneveld JC, Armstrong TS, Ruda R, Wen PY, Weller M, Koekkoek JA, Mittal S, Arakawa Y, Choucair A, Gonzalez-Martinez J, MacDonald DR, Nishikawa R, et al. Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials. Neuro-Oncology. PMID 27651472 DOI: 10.1093/neuonc/now190  1
2016 Armstrong TS, Shade MY, Breton G, Gilbert MR, Mahajan A, Scheurer ME, Vera E, Berger AM. Sleep-wake disturbance in patients with brain tumors. Neuro-Oncology. PMID 27286798 DOI: 10.1093/Neuonc/Now119  1
2016 Ramaswamy V, Hielscher T, Mack SC, Lassaletta A, Lin T, Pajtler KW, Jones DT, Luu B, Cavalli FM, Aldape K, Remke M, Mynarek M, Rutkowski S, Gururangan S, McLendon RE, ... ... Armstrong TS, et al. Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27269943 DOI: 10.1200/Jco.2015.65.7825  1
2016 Day J, Yust-Katz S, Cachia D, Wefel J, Katz LH, Tremont I, Bulbeck H, Armstrong T, Rooney AG. Interventions for the management of fatigue in adults with a primary brain tumour. The Cochrane Database of Systematic Reviews. 4: CD011376. PMID 27074263 DOI: 10.1002/14651858.CD011376.pub2  1
2016 Wu J, Armstrong TS, Gilbert MR. Biology and management of ependymomas. Neuro-Oncology. PMID 27022130 DOI: 10.1093/Neuonc/Now016  1
2016 Helfer JL, Wen PY, Blakeley J, Gilbert MR, Armstrong TS. Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials clinical outcome assessment endpoints workshop (October 15, 2014, Bethesda MD). Neuro-Oncology. 18: ii26-ii36. PMID 26989130 DOI: 10.1093/Neuonc/Nov270  1
2016 Armstrong TS, Bishof AM, Brown PD, Klein M, Taphoorn MJ, Theodore-Oklota C. Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report. Neuro-Oncology. 18: ii1-ii12. PMID 26989127 DOI: 10.1093/neuonc/nov267  1
2016 Reijneveld JC, Armstrong TS. Psycho-oncology. Handbook of Clinical Neurology. 134: 305-13. PMID 26948362 DOI: 10.1016/B978-0-12-802997-8.00018-9  0.01
2015 Armstrong TS, Grant R, Gilbert MR, Lee JW, Norden AD. Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy. Neuro-Oncology. PMID 26527735 DOI: 10.1093/Neuonc/Nov269  1
2015 Cachia D, Kamiya-Matsuoka C, Mandel JJ, Olar A, Cykowski MD, Armstrong TS, Fuller GN, Gilbert MR, De Groot JF. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. Journal of Neuro-Oncology. PMID 26354773 DOI: 10.1007/S11060-015-1930-Y  1
2015 Ladha H, Pawar T, Gilbert MR, Mandel J, O-Brien B, Conrad C, Fields M, Hanna T, Loch C, Armstrong TS. Wound healing complications in brain tumor patients on Bevacizumab. Journal of Neuro-Oncology. PMID 26298437 DOI: 10.1007/S11060-015-1868-0  1
2015 Armstrong TS, Vera-Bolanos E, Acquaye AA, Gilbert MR, Ladha H, Mendoza T. The symptom burden of primary brain tumors: evidence for a core set of tumor and treatment-related symptoms. Neuro-Oncology. PMID 26289592 DOI: 10.1093/Neuonc/Nov166  1
2015 Acquaye AA, Lin L, Vera-Bolanos E, Gilbert MR, Armstrong TS. Hope and mood changes throughout the primary brain tumor illness trajectory. Neuro-Oncology. PMID 26109686 DOI: 10.1093/Neuonc/Nov101  1
2015 Dirven L, Armstrong TS, Taphoorn MJ. Health-related quality of life and other clinical outcome assessments in brain tumor patients: challenges in the design, conduct and interpretation of clinical trials. Neuro-Oncology Practice. 2: 2-5. PMID 26034635 DOI: 10.1093/nop/npv002  0.01
2015 Yust-Katz S, Mandel JJ, Wu J, Yuan Y, Webre C, Pawar TA, Lhadha HS, Gilbert MR, Armstrong TS. Venous thromboembolism (VTE) and glioblastoma. Journal of Neuro-Oncology. 124: 87-94. PMID 25985958 DOI: 10.1200/Jco.2014.32.15_Suppl.2033  1
2015 Pajtler KW, Witt H, Sill M, Jones DT, Hovestadt V, Kratochwil F, Wani K, Tatevossian R, Punchihewa C, Johann P, Reimand J, Warnatz HJ, Ryzhova M, Mack S, Ramaswamy V, ... ... Armstrong TS, et al. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. Cancer Cell. 27: 728-43. PMID 25965575 DOI: 10.1016/J.Ccell.2015.04.002  1
2015 Liu Y, Zhou R, Sulman EP, Scheurer ME, Boehling N, Armstrong GN, Tsavachidis S, Liang FW, Etzel CJ, Conrad CA, Gilbert MR, Armstrong TS, Bondy ML, Wefel JS. Genetic Modulation of Neurocognitive Function in Glioma Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 3340-6. PMID 25904748 DOI: 10.1158/1078-0432.Ccr-15-0168  1
2015 Armstrong TS, Ying Y, Wu J, Acquaye AA, Vera-Bolanos E, Gilbert MR, Brown PD, Vardy J, Chung C. The relationship between corticosteroids and symptoms in patients with primary brain tumors: utility of the Dexamethasone Symptom Questionnaire-Chronic. Neuro-Oncology. 17: 1114-20. PMID 25862766 DOI: 10.1093/Neuonc/Nov054  1
2015 Lin L, Chien LC, Acquaye AA, Vera-Bolanos E, Gilbert MR, Armstrong TS. Significant predictors of patients' uncertainty in primary brain tumors. Journal of Neuro-Oncology. 122: 507-15. PMID 25805495 DOI: 10.1007/S11060-015-1756-7  1
2015 Olar A, Wani KM, Alfaro-Munoz KD, Heathcock LE, van Thuijl HF, Gilbert MR, Armstrong TS, Sulman EP, Cahill DP, Vera-Bolanos E, Yuan Y, Reijneveld JC, Ylstra B, Wesseling P, Aldape KD. IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas. Acta Neuropathologica. 129: 585-96. PMID 25701198 DOI: 10.1007/S00401-015-1398-Z  1
2015 Cachia D, Wani K, Penas-Prado M, Olar A, McCutcheon IE, Benjamin RS, Armstrong TS, Gilbert MR, Aldape KD. C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma. Brain Tumor Pathology. 32: 105-11. PMID 25388523 DOI: 10.1007/S10014-014-0205-1  1
2015 Walbert T, Mendoza TR, Vera-Bolaños E, Acquaye A, Gilbert MR, Armstrong TS. Symptoms and socio-economic impact of ependymoma on adult patients: results of the Adult Ependymoma Outcomes Project 2. Journal of Neuro-Oncology. 121: 341-8. PMID 25359395 DOI: 10.1007/S11060-014-1638-4  1
2015 Brassil KJ, Engebretson JC, Armstrong TS, Segovia JH, Worth LL, Summers BL. Exploring the Cancer Experiences of Young Adults in the Context of Stem Cell Transplantation. Cancer Nursing. 38: 260-9. PMID 25232959 DOI: 10.1097/NCC.0000000000000200  1
2015 Vera-Bolanos E, Aldape K, Yuan Y, Wu J, Wani K, Necesito-Reyes MJ, Colman H, Dhall G, Lieberman FS, Metellus P, Mikkelsen T, Omuro A, Partap S, Prados M, Robins HI, ... ... Armstrong TS, et al. Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients. Neuro-Oncology. 17: 440-7. PMID 25121770 DOI: 10.1093/Neuonc/Nou162  1
2014 Kamiya-Matsuoka C, Cachia D, Olar A, Armstrong TS, Gilbert MR. Primary brain tumors and posterior reversible encephalopathy syndrome. Neuro-Oncology Practice. 1: 184-190. PMID 26034631 DOI: 10.1093/Nop/Npu024  1
2014 Cahill JE, Lin L, LoBiondo-Wood G, Armstrong TS, Acquaye AA, Vera-Bolanos E, Gilbert MR, Padhye NS. Personal health records, symptoms, uncertainty, and mood in brain tumor patients. Neuro-Oncology Practice. 1: 64-70. PMID 26034618 DOI: 10.1093/Nop/Npu005  1
2014 Armstrong TS, Vera-Bolanos E, Acquaye A, Gilbert MR, Mendoza TR. Impact of recall period on primary brain tumor patient's self-report of symptoms. Neuro-Oncology Practice. 1: 55-63. PMID 26034617 DOI: 10.1093/Nop/Npu006  1
2014 Gilbert MR, Armstrong TS, Pope WB, van den Bent MJ, Wen PY. Facing the future of brain tumor clinical research. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5591-600. PMID 25398842 DOI: 10.1158/1078-0432.Ccr-14-0835  1
2014 Brady VJ, Grimes D, Armstrong T, LoBiondo-Wood G. Management of steroid-induced hyperglycemia in hospitalized patients with cancer: a review. Oncology Nursing Forum. 41: E355-65. PMID 25355031 DOI: 10.1188/14.ONF.E355-E365  1
2014 Armstrong TS, Mendoza TR. Response to Lai et al., "development of a symptom index for patients with primary brain tumors". Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: 752-3. PMID 25237001 DOI: 10.1016/j.jval.2014.06.004  1
2014 Armstrong TS, Gilbert MR. Patient reported endpoints for measuring clinical benefit in (high grade glioma) primary brain tumor patients. Current Treatment Options in Oncology. 15: 519-28. PMID 25173554 DOI: 10.1007/S11864-014-0302-8  1
2014 Corwin EJ, Berg JA, Armstrong TS, DeVito Dabbs A, Lee KA, Meek P, Redeker N. Envisioning the future in symptom science. Nursing Outlook. 62: 346-51. PMID 25085330 DOI: 10.1016/J.Outlook.2014.06.006  1
2014 Armstrong TS. 2013 Special Topics Conference: Peaks and pitfalls in longitudinal studies of symptom outcome data. Nursing Outlook. 62: 305-12. PMID 25015407 DOI: 10.1016/j.outlook.2014.05.005  1
2014 Tsai CJ, Wang Y, Allen PK, Mahajan A, McCutcheon IE, Rao G, Rhines LD, Tatsui CE, Armstrong TS, Maor MH, Chang EL, Brown PD, Li J. Outcomes after surgery and radiotherapy for spinal myxopapillary ependymoma: update of the MD Anderson Cancer Center experience. Neurosurgery. 75: 205-14; discussion 2. PMID 24818785 DOI: 10.1227/NEU.0000000000000408  1
2014 Gilbert MR, Dignam J, Pugh S, Armstrong TS, Wefel JS, Aldape K, Stupp R, Hegi M, Won M, Curran WJ, Mehta MP. Reply to M.C. Chamberlain. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 1634-5. PMID 24752060 DOI: 10.1200/Jco.2013.54.9717  1
2014 Yust-Katz S, de Groot JF, Liu D, Wu J, Yuan Y, Anderson MD, Conrad CA, Milbourne A, Gilbert MR, Armstrong TS. Pregnancy and glial brain tumors. Neuro-Oncology. 16: 1289-94. PMID 24615863 DOI: 10.1093/Neuonc/Nou019  1
2014 Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S, Won M, Jeraj R, Brown PD, Jaeckle KA, Schiff D, Stieber VW, et al. A randomized trial of bevacizumab for newly diagnosed glioblastoma. The New England Journal of Medicine. 370: 699-708. PMID 24552317 DOI: 10.1056/Nejmoa1308573  1
2014 Cahill JE, Gilbert MR, Armstrong TS. Personal health records as portal to the electronic medical record. Journal of Neuro-Oncology. 117: 1-6. PMID 24477621 DOI: 10.1007/S11060-013-1333-X  1
2013 Dignam J, Won M, Blumenthal DT, Vogelbaum MA, Aldape KD, Colman H, Chakravarti A, Jeraj R, Armstrong TS, Wefel JS, Brown PD, Jaeckle KA, Schiff D, Atkins JN, Brachman D, et al. RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1. PMID 28136057 DOI: 10.1200/jco.2013.31.18_suppl.1  1
2013 Armstrong TS, Wefel JS, Wang M, Gilbert MR, Won M, Bottomley A, Mendoza TR, Coens C, Werner-Wasik M, Brachman DG, Choucair AK, Mehta M. Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 4076-84. PMID 24101048 DOI: 10.1200/Jco.2013.49.6067  1
2013 Gilbert MR, Wang M, Aldape KD, Stupp R, Hegi ME, Jaeckle KA, Armstrong TS, Wefel JS, Won M, Blumenthal DT, Mahajan A, Schultz CJ, Erridge S, Baumert B, Hopkins KI, et al. Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 4085-91. PMID 24101040 DOI: 10.1200/Jco.2013.49.6968  1
2013 Ghia AJ, Mahajan A, Allen PK, Armstrong TS, Lang FF, Gilbert MR, Brown PD. Supratentorial gross-totally resected non-anaplastic ependymoma: population based patterns of care and outcomes analysis. Journal of Neuro-Oncology. 115: 513-20. PMID 24085643 DOI: 10.1007/S11060-013-1254-8  1
2013 Acquaye AA, Vera-Bolanos E, Armstrong TS, Gilbert MR, Lin L. Mood disturbance in glioma patients. Journal of Neuro-Oncology. 113: 505-12. PMID 23677748 DOI: 10.1007/s11060-013-1143-1  1
2013 Lin L, Chiang HH, Acquaye AA, Vera-Bolanos E, Gilbert MR, Armstrong TS. Uncertainty, mood states, and symptom distress in patients with primary brain tumors: analysis of a conceptual model using structural equation modeling. Cancer. 119: 2796-806. PMID 23661311 DOI: 10.1002/cncr.28121  1
2013 Raghunathan A, Wani K, Armstrong TS, Vera-Bolanos E, Fouladi M, Gilbertson R, Gajjar A, Goldman S, Lehman NL, Metellus P, Mikkelsen T, Necesito-Reyes MJ, Omuro A, Packer RJ, Partap S, et al. Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system. Brain Pathology (Zurich, Switzerland). 23: 584-94. PMID 23452038 DOI: 10.1111/Bpa.12050  1
2013 Armstrong TS. Measuring clinical benefit: use of patient-reported outcomes (PRO) in primary brain tumor clinical trials. Current Oncology Reports. 15: 27-32. PMID 23054936 DOI: 10.1007/s11912-012-0276-2  1
2012 Armstrong TS, Gilbert MR. Practical strategies for management of fatigue and sleep disorders in people with brain tumors. Neuro-Oncology. 14: iv65-72. PMID 23095832 DOI: 10.1093/Neuonc/Nos210  1
2012 Lin L, Acquaye AA, Vera-Bolanos E, Cahill JE, Gilbert MR, Armstrong TS. Validation of the Mishel's uncertainty in illness scale-brain tumor form (MUIS-BT). Journal of Neuro-Oncology. 110: 293-300. PMID 22965831 DOI: 10.1007/S11060-012-0971-8  1
2012 Amirian ES, Armstrong TS, Aldape KD, Gilbert MR, Scheurer ME. Predictors of survival among pediatric and adult ependymoma cases: a study using Surveillance, Epidemiology, and End Results data from 1973 to 2007. Neuroepidemiology. 39: 116-24. PMID 22846789 DOI: 10.1159/000339320  1
2012 Cahill J, LoBiondo-Wood G, Bergstrom N, Armstrong T. Brain tumor symptoms as antecedents to uncertainty: an integrative review. Journal of Nursing Scholarship : An Official Publication of Sigma Theta Tau International Honor Society of Nursing / Sigma Theta Tau. 44: 145-55. PMID 22564342 DOI: 10.1111/j.1547-5069.2012.01445.x  1
2012 Galanis E, Wu W, Cloughesy T, Lamborn K, Mann B, Wen PY, Reardon DA, Wick W, Macdonald D, Armstrong TS, Weller M, Vogelbaum M, Colman H, Sargent DJ, van den Bent MJ, et al. Phase 2 trial design in neuro-oncology revisited: a report from the RANO group. The Lancet. Oncology. 13: e196-204. PMID 22554547 DOI: 10.1016/S1470-2045(11)70406-5  1
2012 Armstrong TS, Wefel JS, Gning I, Acquaye A, Vera-Bolanos E, Gilbert MR, Cleeland CS, Mendoza T. Congruence of primary brain tumor patient and caregiver symptom report. Cancer. 118: 5026-37. PMID 22415423 DOI: 10.1002/Cncr.27483  1
2012 Wani K, Armstrong TS, Vera-Bolanos E, Raghunathan A, Ellison D, Gilbertson R, Vaillant B, Goldman S, Packer RJ, Fouladi M, Pollack I, Mikkelsen T, Prados M, Omuro A, Soffietti R, et al. A prognostic gene expression signature in infratentorial ependymoma. Acta Neuropathologica. 123: 727-38. PMID 22322993 DOI: 10.1007/S00401-012-0941-4  1
2012 Armstrong TS, Wen PY, Gilbert MR, Schiff D. Management of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumors. Neuro-Oncology. 14: 1203-14. PMID 22307472 DOI: 10.1093/Neuonc/Nor223  1
2012 Penas-Prado M, Armstrong TS, Gilbert MR. Glioblastoma. Handbook of Clinical Neurology. 105: 485-506. PMID 22230514 DOI: 10.1016/B978-0-444-53502-3.00004-5  1
2012 Amirian ES, Armstrong TS, Gilbert MR, Scheurer ME. Predictors of survival among older adults with ependymoma. Journal of Neuro-Oncology. 107: 183-9. PMID 21952907 DOI: 10.1007/S11060-011-0730-2  1
2011 Gilbert MR, Wang M, Aldape KD, Stupp R, Hegi M, Jaeckle KA, Armstrong TS, Wefel JS, Won M, Blumenthal DT, Mahajan A, Schultz CJ, Erridge SC, Brown PD, Chakravarti A, et al. RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2006. PMID 28023891 DOI: 10.1200/Jco.2011.29.15_Suppl.2006  1
2011 Armstrong TS, Wefel JS, Wang M, Won M, Bottomley A, Mendoza TR, Coens C, Werner-Wasik M, Brachman D, Choucair AK, Gilbert MR. Clinical utility of neurocognitive function (NCF), quality of life (QOL), and symptom assessment as prognostic factors for survival and measures of treatment effects on RTOG 0525. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2016. PMID 28023866 DOI: 10.1200/Jco.2011.29.15_Suppl.2016  1
2011 Shonka NA, Armstrong TS, Prabhu SS, Childress A, Choi S, Langford LA, Gilbert MR. Atypical teratoid/rhabdoid tumors in adults: a case report and treatment-focused review. Journal of Clinical Medicine Research. 3: 85-92. PMID 21811535 DOI: 10.4021/Jocmr535W  1
2011 Armstrong TS, Vera-Bolanos E, Gilbert MR. Clinical course of adult patients with ependymoma: results of the Adult Ependymoma Outcomes Project. Cancer. 117: 5133-41. PMID 21538344 DOI: 10.1002/Cncr.26181  1
2011 Cahill JE, Armstrong TS. Caring for an adult with a malignant primary brain tumor. Nursing. 41: 28-33; quiz 33-4. PMID 21537213 DOI: 10.1097/01.NURSE.0000397930.50420.c6  1
2011 van den Bent MJ, Wefel JS, Schiff D, Taphoorn MJ, Jaeckle K, Junck L, Armstrong T, Choucair A, Waldman AD, Gorlia T, Chamberlain M, Baumert BG, Vogelbaum MA, Macdonald DR, Reardon DA, et al. Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. The Lancet. Oncology. 12: 583-93. PMID 21474379 DOI: 10.1016/S1470-2045(11)70057-2  1
2011 Armstrong TS, Vera-Bolanos E, Gning I, Acquaye A, Gilbert MR, Cleeland C, Mendoza T. The impact of symptom interference using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on prediction of recurrence in primary brain tumor patients. Cancer. 117: 3222-8. PMID 21264841 DOI: 10.1002/Cncr.25892  1
2011 Armstrong TS, Gilbert MR. Patient profiling for treatment toxicity: potential use of clinical and genomic factors. Current Oncology Reports. 13: 37-41. PMID 21080116 DOI: 10.1007/S11912-010-0141-0  1
2011 Armstrong TS, Prabhu S, Aldape K, Hossan B, Kang S, Childress A, Tolentino L, Gilbert MR. A case of soft tissue metastasis from glioblastoma and review of the literature. Journal of Neuro-Oncology. 103: 167-72. PMID 20809248 DOI: 10.1007/S11060-010-0370-Y  1
2010 Armstrong TS, Vera-Bolanos E, Bekele BN, Aldape K, Gilbert MR. Adult ependymal tumors: prognosis and the M. D. Anderson Cancer Center experience. Neuro-Oncology. 12: 862-70. PMID 20511182 DOI: 10.1093/Neuonc/Noq009  1
2010 Liu Y, Shete S, Etzel CJ, Scheurer M, Alexiou G, Armstrong G, Tsavachidis S, Liang FW, Gilbert M, Aldape K, Armstrong T, Houlston R, Hosking F, Robertson L, Xiao Y, et al. Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 2467-74. PMID 20368557 DOI: 10.1200/Jco.2009.26.6213  1
2010 Armstrong TS, Gning I, Mendoza TR, Vera-Bolanos E, Gilbert MR, Rhines LD, Weinberg JS, Sanchez-Williams G, Levin V, Burton AW, Cleeland C. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module. Journal of Neurosurgery. Spine. 12: 421-30. PMID 20367379 DOI: 10.3171/2009.10.Spine0943  1
2010 Armstrong TS, Cron SG, Bolanos EV, Gilbert MR, Kang DH. Risk factors for fatigue severity in primary brain tumor patients. Cancer. 116: 2707-15. PMID 20235192 DOI: 10.1002/Cncr.25018  1
2010 Armstrong TS, Choi S, Walker J, Gilbert MR. Seizure risk in brain tumor patients with conversion to generic levetiracetam. Journal of Neuro-Oncology. 98: 137-41. PMID 19936624 DOI: 10.1007/S11060-009-0066-3  1
2009 Armstrong TS. Head's up on the treatment of malignant glioma patients. Oncology Nursing Forum. 36: E232-40. PMID 19726382 DOI: 10.1188/09.ONF.E232-E240  1
2009 Lambert LA, Armstrong TS, Lee JJ, Liu S, Katz MH, Eng C, Wolff RA, Tortorice ML, Tansey P, Gonzalez-Moreno S, Lambert DH, Mansfield PF. Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin C. Annals of Surgical Oncology. 16: 2181-7. PMID 19475451 DOI: 10.1245/s10434-009-0523-4  1
2009 Armstrong TS, Cao Y, Scheurer ME, Vera-Bolaños E, Manning R, Okcu MF, Bondy M, Zhou R, Gilbert MR. Risk analysis of severe myelotoxicity with temozolomide: the effects of clinical and genetic factors. Neuro-Oncology. 11: 825-32. PMID 19179423 DOI: 10.1215/15228517-2008-120  1
2009 Armstrong TS, Gning I, Mendoza TR, Weinberg JS, Gilbert MR, Tortorice ML, Cleeland CS. Clinical utility of the MDASI-BT in patients with brain metastases. Journal of Pain and Symptom Management. 37: 331-40. PMID 18676120 DOI: 10.1016/J.Jpainsymman.2008.02.011  1
2008 Armstrong TS, Cao Y, Vera E, Scheurer ME, Manning R, Okcu MF, Bondy M, Gilbert MR. Pharmacoepidemiology of myelotoxicity (TOX) with temozolomide (TMZ) in malignant glioma patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 9548. PMID 27948137 DOI: 10.1200/Jco.2008.26.15_Suppl.9548  1
2008 Armstrong TS, Gilbert MR. Use of complementary and alternative medical therapy by patients with primary brain tumors. Current Neurology and Neuroscience Reports. 8: 264-8. PMID 18541122 DOI: 10.1007/S11910-008-0040-Z  1
2008 Lee EL, Armstrong TS. Increased intracranial pressure. Clinical Journal of Oncology Nursing. 12: 37-41. PMID 18258573 DOI: 10.1188/08.CJON.37-41  1
2008 Tremont-Lukats I, Ratilal BO, Armstrong T, Gilbert MR. Antiepileptic drugs for preventing seizures in people with brain tumors Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.Cd004424.Pub2  1
2007 Gilbert MR, Armstrong TS. Management of patients with newly diagnosed malignant primary brain tumors with a focus on the evolving role of temozolomide. Therapeutics and Clinical Risk Management. 3: 1027-33. PMID 18516257  1
2007 Westcarth L, Armstrong T. Seizures in people with cancer Clinical Journal of Oncology Nursing. 11: 33-37. PMID 17441395  1
2007 Armstrong TS, Gilbert MR. Net clinical benefit: functional endpoints in brain tumor clinical trials. Current Oncology Reports. 9: 60-5. PMID 17164049 DOI: 10.1007/Bf02951427  1
2006 Armstrong T, Cohen MZ, Hess KR, Manning R, Lee EL, Tamayo G, Baumgartner K, Min SJ, Yung A, Gilbert M. Complementary and alternative medicine use and quality of life in patients with primary brain tumors. Journal of Pain and Symptom Management. 32: 148-54. PMID 16877182 DOI: 10.1016/J.Jpainsymman.2006.02.015  1
2006 Armstrong TS, Mendoza T, Gning I, Gring I, Coco C, Cohen MZ, Eriksen L, Hsu MA, Gilbert MR, Cleeland C. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT). Journal of Neuro-Oncology. 80: 27-35. PMID 16598415 DOI: 10.1007/S11060-006-9135-Z  1
2005 Chawathe M, Zatman T, Hall JE, Gildersleve C, Jones RM, Wilkes AR, Aguilera IM, Armstrong TS. Sevoflurane (12% and 8%) inhalational induction in children. Paediatric Anaesthesia. 15: 470-5. PMID 15910347 DOI: 10.1111/j.1460-9592.2005.01478.x  1
2005 Armstrong TS, Cohen MZ, Eriksen L, Cleeland C. Content validity of self-report measurement instruments: an illustration from the development of the Brain Tumor Module of the M.D. Anderson Symptom Inventory. Oncology Nursing Forum. 32: 669-76. PMID 15897941 DOI: 10.1188/05.ONF.669-676  1
2005 Armstrong T, Almadrones L, Gilbert MR. Chemotherapy-induced peripheral neuropathy Oncology Nursing Forum. 32: 305-311. PMID 15759068 DOI: 10.1188/05.Onf.305-311  1
2004 Armstrong TS, Cohen MZ, Weinberg J, Gilbert MR. Imaging techniques in neuro-oncology. Seminars in Oncology Nursing. 20: 231-9. PMID 15612599 DOI: 10.1016/J.Soncn.2004.07.003  1
2004 Armstrong TS. Intracranial tumors. Seminars in Oncology Nursing. 20: 221-3. PMID 15612597 DOI: 10.1016/j.soncn.2004.07.001  1
2004 Armstrong TS, Cohen MZ, Eriksen LR, Hickey JV. Symptom clusters in oncology patients and implications for symptom research in people with primary brain tumors. Journal of Nursing Scholarship : An Official Publication of Sigma Theta Tau International Honor Society of Nursing / Sigma Theta Tau. 36: 197-206. PMID 15495487 DOI: 10.1111/j.1547-5069.2004.04038.x  1
2004 Armstrong TS, Gilbert MR. The treatment of neoplastic meningitis. Expert Opinion On Pharmacotherapy. 5: 1929-35. PMID 15330730 DOI: 10.1517/14656566.5.9.1929  1
2004 Armstrong T, Gilbert MR. Central nervous system toxicity from cancer treatment Current Oncology Reports. 6: 11-19. PMID 14664755 DOI: 10.1007/S11912-996-0004-X  1
2003 Armstrong TS. Symptoms experience: a concept analysis. Oncology Nursing Forum. 30: 601-6. PMID 12861321 DOI: 10.1188/03.ONF.601-606  1
2003 Armstrong TS, Kanusky JT, Gilbert MR. Seize the moment to learn about epilepsy in people with cancer. Clinical Journal of Oncology Nursing. 7: 163-9. PMID 12696212 DOI: 10.1188/03.Cjon.163-169  1
2002 Armstrong TS, Gilbert MR. Glial tumors--new approaches in chemotherapy. The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses. 34: 326-30. PMID 12506816 DOI: 10.1097/01376517-200212000-00007  1
2002 Crowley GH, Leffel R, Ramirez D, Hart JL, Armstrong TS. User perceptions of the librabry's Web pages: A Focus Group Study at Texas A&M University Journal of Academic Librarianship. 28: 205-210. DOI: 10.1016/S0099-1333(02)00284-7  1
2000 Armstrong T, Hancock C. Temodar offers promise for treating astrocytomas Clinical Journal of Oncology Nursing. 4: 159-160. PMID 2001136677  1
2000 Armstrong TS, Johnston IG. Which women want food during labour?: results of an audit in a Scottish DGH. Health Bulletin. 58: 141-4. PMID 12813843  1
2000 Armstrong TS, Gilbert MR. Metastatic brain tumors: diagnosis, treatment, and nursing interventions. Clinical Journal of Oncology Nursing. 4: 217-25. PMID 11111453  1
2000 Gilbert M, Armstrong T, Meyers C. Issues in assessing and interpreting quality of life in patients with malignant glioma Seminars in Oncology. 27: 20-26. PMID 10866346  1
2000 Armstrong T, Hancock C, Gilbert M. Symptom management of the patient with a brain tumor at the end of life Oncology Nursing Forum. 27: 616. PMID 10833685  1
2000 Armstrong T, Gilbert MR. Article on deep vein thrombosis should address primary brain tumors Oncology Nursing Forum. 27: 426-427. PMID 10785896  1
2000 Armstrong TS, Aitken HL. The developing role of play preparation in paediatric anaesthesia. Paediatric Anaesthesia. 10: 1-4. PMID 10632902  0.01
1999 Martin MJ, Armstrong TS, Johnston GM, Youngson GG. Return of the internal jugular vein--development of collateral drainage following neonatal ligation of the vein. Paediatric Anaesthesia. 9: 271-2. PMID 10320611  1
1999 Armstrong TS. Harvesting hope in the autumn of life. Clinical Journal of Oncology Nursing. 3: 23-8. PMID 10232169  1
1999 Armstrong TS, Johnston GM. Preoxygenation in infants and children. Paediatric Anaesthesia. 9: 177-8. PMID 10189664  1
1998 Armstrong TS, Barr JM. Latex allergy--strategies for management. Anaesthesia. 53: 1236. PMID 10193244  1
1998 Armstrong TS, Martin PD. Anaesthesia for telescopic procedures in the thorax. British Journal of Anaesthesia. 81: 482. PMID 9861146  1
1998 Armstrong TS, Byers GF, Johnston GM. Tracheal intubation in infants. Anesthesia and Analgesia. 87: 1455-7. PMID 9842854  1
1998 Armstrong TS, Gilbert MR. Chemotherapy of astrocytomas: an overview. Seminars in Oncology Nursing. 14: 18-25. PMID 9503511  1
1997 Armstrong TS, Johnston IG. Epidural service implications of a feeding policy in labour. Anaesthesia. 52: 798-9. PMID 9304355  1
1997 Armstrong TS, Martin PD. Propofol, fluoxetine and spontaneous movement. Anaesthesia. 52: 809-10. PMID 9291791  1
1996 Armstrong TS, Gilbert MR. Glial neoplasms: classification, treatment, and pathways for the future. Oncology Nursing Forum. 23: 615-25; quiz 626-7. PMID 8735320  1
1995 Gilbert MR, Armstrong TS. Management of seizures in the adult patient with cancer. Cancer Practice. 3: 143-9. PMID 7599670  1
1994 Armstrong TS. Stomatitis in the bone marrow transplant patient. An overview and proposed oral care protocol. Cancer Nursing. 17: 403-10. PMID 7954388  1
1980 Mangelsdorff AD, Hubbart JA, Armstrong TS. Prediction of staffing in selected Army medical treatment facilities. Military Medicine. 145: 204-5. PMID 6771691  1
Show low-probability matches.